Milestone Pharmaceuticals Inc.
MIST· Nasdaq
Released May 24, 2019, after the close
10-Q filed Jun 19, 2019, 80 days after period end · 0001104659-19-036365
| Metric | Q1 2019 | Q1 2018 |
|---|---|---|
| Net Income | -$10.45M | -$4.18M |
| EPS Diluted | -$17.32 | -$15.57 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Milestone Pharmaceuticals Inc. · CIK 1408443 · Engraved from SEC EDGAR
ended Mar 31, 2019 · filed Jun 19, 2019 · 80 d after period end